← Mechanisms of action
IL13
SINGLE PROTEINHomo sapiens
Preferred name: Interleukin-13 ChEMBL ↗
Linked proteins
Drugs acting on this target (25)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| BITS-7201A | Antagonist | experimental | mAb | IL13 |
| pitrakinra | Antagonist | experimental | Recombinant protein | IL13 antagonist |
| romilkimab | Antagonist | experimental | mAb | IL13 |
| cintredekin besudotox | Binding agent | experimental | Recombinant protein | IL13 binding agent |
| sar443765 | Binding agent | experimental | mAb | IL13 |
| anrukinzumab | Inhibitor | experimental | mAb | IL13 inhibitor |
| apg777 | Inhibitor | experimental | mAb | IL13 inhibitor |
| atto-3712 | Inhibitor | experimental | mAb | IL13 inhibitor |
| cc-93538 | Inhibitor | experimental | mAb | Interleukin-13 inhibitor |
| cnto-5825 | Inhibitor | experimental | mAb | IL13 inhibitor |
| gb-7624 | Inhibitor | experimental | mAb | IL13 inhibitor |
| gsk2434735 | Inhibitor | experimental | mAb | IL13 inhibitor |
| gsk679586 | Inhibitor | experimental | mAb | IL13 inhibitor |
| ima-026 | Inhibitor | experimental | mAb | IL13 inhibitor |
| lebrikizumab | Inhibitor | approved | mAb | IL13 inhibitor |
| medi7836 | Inhibitor | experimental | mAb | IL13 inhibitor |
| qax-576 | Inhibitor | experimental | mAb | IL13 inhibitor |
| qax567 | Inhibitor | experimental | mAb | IL13 inhibitor |
| qbx258 | Inhibitor | experimental | mAb | IL13 inhibitor |
| rg1671 | Inhibitor | experimental | mAb | IL13 inhibitor |
| romilkimab | Inhibitor | experimental | mAb | Interleukin-13 inhibitor |
| tralokinumab (Adtralza) | Inhibitor | approved | mAb | IL13 inhibitor |
| vak694 | Inhibitor | experimental | mAb | IL13 inhibitor |
| vr942 | Inhibitor | experimental | mAb | IL13 inhibitor |
| zl-1503 | Inhibitor | experimental | mAb | IL13 inhibitor |